Julie R. Park, MD, on Neuroblastoma: Results of a Children’s Oncology Group Study

2016 ASCO Annual Meeting
Tweet this page

Julie R. Park, MD, of Seattle Children’s Hospital, discusses findings from this phase III trial of tandem myeloablative autologous stem cell transplant using peripheral blood stem cell as consolidation therapy for high-risk neuroblastoma (Abstract LBA3).

Advertisement

Advertisement



Advertisement